Evidence map›Paper›PMID 28356942›Full record

ArticleOncology letters2017

Anti-metastatic activity of fangchinoline in human gastric cancer AGS cells.

Zhengrong Chen, Tengfei He, Kui Zhao, Chungen Xing

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Anticancer effects of fangchinoline in 4T1 breast cancer cells:Contemporary oncology (Poznan, Poland) · 2026
    Article
  2. Article
  3. Effect ofMolecules (Basel, Switzerland) · 2020
    Article
  4. A critical review: traditional uses, phytochemistry, pharmacology and toxicology ofPhytochemistry reviews : proceedings of the Phytochemical Society of Europe · 2020
    Review
  5. Article
  6. Cepharanthine: An update of its mode of action, pharmacological properties and medical applications.Phytomedicine : international journal of phytotherapy and phytopharmacology · 2019
    Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Zhengrong ChenDepartment of General Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215007, P.R. China.
Tengfei HeDepartment of General Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215007, P.R. China.
Kui ZhaoDepartment of General Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215007, P.R. China.
Chungen XingDepartment of General Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215007, P.R. China.
Soochow University · CNSecond Affiliated Hospital of Soochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fangchinoline (FCL) is an active component isolated from the traditional medicinal plant

Indexed as

AKTfangchinolinegastric cancermetastasisMMPs

Identifiers

PMID28356942
PMCPMC5351403
OpenAlexW2558540759

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.